newsfilter
← Latest News
GlobeNewswire·

23andMe Announces CEO's Take-Private Proposal

ME

SOUTH SAN FRANCISCO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME), a leading human genetics and biopharmaceutical company, has received a preliminary non-binding indication of interest from